{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:13:56Z","timestamp":1789071236027,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["BCF-KH-IIT\\u2212202306\\u201321"],"award-info":[{"award-number":["BCF-KH-IIT\\u2212202306\\u201321"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.survophthal.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:43:58Z","timestamp":1780616638000},"page":"1665-1674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroids for the treatment of diabetic macular edema with massive hard exudates: An evidence-based update."],"prefix":"10.1016","volume":"71","author":[{"given":"Shiya","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1956-9507","authenticated-orcid":false,"given":"Xuhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2026.06.005_bib1","doi-asserted-by":"crossref","unstructured":"Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98(5 Suppl):786-806.","DOI":"10.1016\/S0161-6420(13)38012-9"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/IAE.0b013e31827e247b","article-title":"Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients","volume":"33","author":"Ad\u00e1n","year":"2013","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamaophthalmol.2015.1823","article-title":"Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15","volume":"133","author":"Aref","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.005_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.eye.6702877","article-title":"Long-term results of excision of plaque-like foveal hard exudates in patients with chronic diabetic macular oedema","volume":"22","author":"Avci","year":"2008","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00417-005-0069-5","article-title":"Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates","volume":"244","author":"Avci","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib6","first-page":"83","article-title":"Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes","volume":"8","author":"Barak","year":"2006","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.005_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib8","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1167\/iovs.13-12008","article-title":"Influence of incisional vitreous incarceration in sclerotomy closure competency after transconjunctival sutureless vitrectomy","volume":"54","author":"Benitez-Herreros","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/24741264221138166","article-title":"Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber","volume":"6","author":"Betsch","year":"2022","journal-title":"J Vitreoretin Dis"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.005_bib10","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10792-007-9120-3","article-title":"Quantitative evaluation of reduction of plaque-like hard exudates in diabetic macular edema after intravitreal triamcinolone injection","volume":"28","author":"Ceki\u00e7","year":"2008","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.005_bib13","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1167\/iovs.10-6387","article-title":"Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib14","article-title":"Cytotoxicity of Triamcinolone Acetonide on Human Retinal Pigment Epithelial Cells","volume":"48","author":"Chang","year":"2007","journal-title":"Invest Opthalmology & Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.exer.2008.03.011","article-title":"vitro benzyl alcohol cytotoxicity: Implications for intravitreal use of triamcinolone acetonide","volume":"86","author":"Chang","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2026.06.005_bib16","article-title":"Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery","volume":"20185832186","author":"Chang","year":"2018","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000496705","article-title":"Treatment of Macular Edema after Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane Using Intravitreal Dexamethasone Implant: Long-Term Outcomes","volume":"242","author":"Chatziralli","year":"2019","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.005_bib18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22","volume":"114","author":"Chew","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.005_bib19","first-page":"121205","article-title":"Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study","author":"Chhablani","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9394(98)00107-X","article-title":"Precipitation of hard exudate after resorption of intraretinal edema after treatment of retinal branch vein occlusion","volume":"126","author":"Christoffersen","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.005_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.2004.041707","article-title":"Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study","volume":"88","author":"Ciardella","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.005_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5301\/ejo.5000768","article-title":"Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema","volume":"26","author":"Costa","year":"2016","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000504890","article-title":"Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience","volume":"243","author":"De Geronimo","year":"2020","journal-title":"Ophthalmologica"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.005_bib24","first-page":"2620","article-title":"Functional alterations of retinal neurons and vascular involvement progress simultaneously in the Psammomys obesus model of diabetic retinopathy","volume":"529","author":"Dellaa","year":"2021","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.survophthal.2026.06.005_bib25","doi-asserted-by":"crossref","DOI":"10.2147\/OPTH.S82562","article-title":"Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide","author":"Dodwell","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.005_bib26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ophtha.2014.10.028","article-title":"Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials","volume":"122","author":"Domalpally","year":"2015","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.005_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jfo.2015.03.002","article-title":"[Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015]","volume":"38","author":"Dot","year":"2015","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ophtha.2021.07.009","article-title":"Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology","volume":"129","author":"Ehlers","year":"2022","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","article-title":"Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes","volume":"109","author":"Ehrchen","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.005_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/02713680500263598","article-title":"Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy","volume":"30","author":"Felinski","year":"2005","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(00)00915-8","article-title":"vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor","volume":"411","author":"Fischer","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/APO.0000000000000194","article-title":"Presumed Sterile Endophthalmitis Afer Intravitreal Triamcinolone (Kenalog)-More Common and Less Benign Than We Thought?","volume":"6","author":"Fong","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.005_bib33","first-page":"873","article-title":"Subretinal fibrosis in diabetic macular edema. ETDRS report 23","volume":"115","author":"Fong","year":"1997","journal-title":"Early Treat Diabet Retin Study Res Group Arch Ophthalmol"},{"issue":"3 Pt 1","key":"10.1016\/j.survophthal.2026.06.005_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9394(21)00232-4","article-title":"Echographic localization of corticosteroids after periocular injection","volume":"103","author":"Freeman","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.005_bib35","article-title":"Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes","volume":"20203946531","author":"Freissinger","year":"2020","journal-title":"J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5301\/ejo.5001059","article-title":"Cauterization of Ozurdex wound for the prevention of scleral leakage in vitrectomized eyes","volume":"28","author":"Furino","year":"2018","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib37","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa","year":"2021","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00006982-200002000-00004","article-title":"Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane","volume":"20","author":"Gandorfer","year":"2000","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1442-9071.2010.02341.x","article-title":"Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial","volume":"38","author":"Gillies","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.005_bib40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IAE.0000000000002475","article-title":"INTRAVITREAL DEXAMETHASONE IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER: A Multicenter Study From the Pan-American Collaborative Retina Study Group","volume":"40","author":"Gon\u00e7alves","year":"2020","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ICB.0b013e31826f08b0","article-title":"Migration of intravitreal dexamethasone implant to anterior chamber","volume":"7","author":"Gullapalli","year":"2013","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/IAE.0b013e31816102f2","article-title":"Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema","volume":"28","author":"Hartley","year":"2008","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.005_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.oftal.2020.06.005","article-title":"Non-pharmacological complications associated with Intravitreal dexamethasone implant injection","volume":"95","author":"Hernanz","year":"2020","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"10.1016\/j.survophthal.2026.06.005_bib44","first-page":"5139","article-title":"Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema","author":"Herrero-Vanrell","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41433-022-01931-9","article-title":"Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study","volume":"37","author":"Iglicki","year":"2023","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib46","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajo.2004.05.028","article-title":"Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection","volume":"138","author":"Inoue","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.eye.6702304","article-title":"Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years","volume":"21","author":"Islam","year":"2007","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.005_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jop.2006.0067","article-title":"The etiology of steroid cataract","volume":"23","author":"James","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2026.06.005_bib49","article-title":"The effect of posterior subtenon methylprednisolone acetate in the refractory diabetic macular edema: a prospective nonrandomized interventional case series","volume":"615","author":"Javadzadeh","year":"2006","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.005_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000093796","article-title":"Intravitreal triamcinolone acetonide: a change in a paradigm","volume":"38","author":"Jonas","year":"2006","journal-title":"Ophthalmic Res"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.005_bib51","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/archopht.123.10.1338","article-title":"Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema","volume":"123","author":"Jonas","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.005_bib52","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00006982-200510000-00003","article-title":"Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates","volume":"25","author":"Khairallah","year":"2005","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.005_bib53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","article-title":"Intraocular pressure monitoring post intravitreal steroids: a systematic review","volume":"58","author":"Kiddee","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.005_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3341\/kjo.2019.0049","article-title":"New Method of Quantitative Analysis of Hard Exudate Using Optical Coherence Tomography: Application in Diabetic Macular Edema","volume":"33","author":"Kim","year":"2019","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/IAE.0000000000004270","article-title":"NONPHARMACOLOGICAL ASPECTS OF INTRAVITREAL DEXAMETHASONE IMPLANT INJECTIONS: A Retrospective Study of 3,430 Injections and Complications","volume":"45","author":"Kiristioglu","year":"2025","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib56","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1185\/030079907X187946","article-title":"The effect of intravitreal triamcinolone on intraocular pressure","volume":"23","author":"Kramar","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib57","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jcjo.2020.06.021","article-title":"Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone","volume":"55","author":"Kuley","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/08820538.2020.1758161","article-title":"Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone","volume":"35","author":"Kuley","year":"2020","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1992.01080140115038","article-title":"Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection","volume":"110","author":"Kwak","year":"1992","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1755-3768.2008.01245.x","article-title":"Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial","volume":"87","author":"Larsson","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"5-6","key":"10.1016\/j.survophthal.2026.06.005_bib61","first-page":"521","article-title":"Rheology of the vitreous body. Part I: Viscoelasticity of human vitreous","volume":"29","author":"Lee","year":"1992","journal-title":"Biorheology"},{"key":"10.1016\/j.survophthal.2026.06.005_bib62","first-page":"24378","article-title":"Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina\/vitreous","author":"Li","year":"2016","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.005_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236867","article-title":"Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.005_bib64","doi-asserted-by":"crossref","first-page":"749","DOI":"10.12669\/pjms.304.4810","article-title":"Subtenon Vs Intravitreal Triamcinolone injection in Diabetic Macular Edema, A prospective study in Chinese population","volume":"30","author":"Luo","year":"2014","journal-title":"Pak J Med Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.005_bib65","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bjo.2007.115386","article-title":"Effects of intravitreal triamcinolone acetonide injection with and without preservative","volume":"91","author":"Maia","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.005_bib66","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00592-020-01561-1","article-title":"Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study","volume":"57","author":"Mathis","year":"2020","journal-title":"Acta Diabetol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.005_bib67","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/bjophthalmol-2015-307797","article-title":"Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial","volume":"100","author":"Mehta","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib68","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00417-003-0661-5","article-title":"The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study","volume":"241","author":"M\u00f8ller","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.005_bib69","first-page":"1071564","article-title":"A review on recent drug delivery systems for posterior segment of eye","author":"Nayak","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib70","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/2008-322X.163771","article-title":"Retinal Sensitivity over Hard Exudates in Diabetic Retinopathy","volume":"10","author":"Raman","year":"2015","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12886-019-1122-1","article-title":"Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration","volume":"19","author":"R\u00f6ck","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/eop.10.20","article-title":"Inflammatory reactions after intravitreal triamcinolone acetonide: possible mechanisms and therapeutic options","volume":"5","author":"Roth","year":"2014","journal-title":"Expert Rev Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5301\/ejo.5000358","article-title":"Is the effect of intravitreal triamcinolone acetonide on diabetic macular edema dose-dependent?","volume":"24","author":"\u0160aric","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.005_bib74","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1167\/iovs.13-11849","article-title":"Quantitative measurement of hard exudates in patients with diabetes and their associations with serum lipid levels","volume":"54","author":"Sasaki","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.005_bib75","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1167\/iovs.05-0565","article-title":"Triamcinolone acetonide destabilizes VEGF mRNA in M\u00fcller cells under continuous cobalt stimulation","volume":"46","author":"Sears","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12886-017-0578-0","article-title":"Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections","volume":"17","author":"Shin","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib77","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/bjo.64.6.392","article-title":"Organised macular plaques in exudative diabetic maculopathy","volume":"64","author":"Sigurdsson","year":"1980","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.005_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1755-3768.2010.01912.x","article-title":"Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema","volume":"90","author":"Soliman","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/IAE.0b013e31818eccb3","article-title":"Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006","volume":"29","author":"Stepien","year":"2009","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00006982-200402000-00004","article-title":"Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy","volume":"24","author":"Takaya","year":"2004","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1083\/jcb.102.1.55","article-title":"Rapid redistribution of clathrin onto macrophage plasma membranes in response to Fc receptor-ligand interaction during frustrated phagocytosis","volume":"102","author":"Takemura","year":"1986","journal-title":"J Cell Biol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/08820530903389775","article-title":"Intravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edema","volume":"24","author":"Tsilimbaris","year":"2009","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib83","first-page":"299","article-title":"Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes","volume":"63","author":"Waage","year":"1988","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.005_bib84","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.oret.2022.12.009","article-title":"A Comparison of Ocular Complications after 0.7 mg Dexamethasone Implant versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes","volume":"7","author":"Wakabayashi","year":"2023","journal-title":"Ophthalmol Retin"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.005_bib85","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1350-9462(98)00035-4","article-title":"Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma","volume":"18","author":"Wordinger","year":"1999","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.005_bib86","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00006982-200002000-00003","article-title":"Surgical treatment for severe diabetic macular edema with massive hard exudates","volume":"20","author":"Yang","year":"2000","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0002-9394(69)90004-X","article-title":"Ocular pathology of diabetes mellitus","volume":"67","author":"Yanoff","year":"1969","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.005_bib88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10792-024-03278-4","article-title":"Effectiveness of dexamethasone implants in treating diabetic macular edema with hard exudates: a clinical observation","volume":"44","author":"Zhao","year":"2024","journal-title":"Int Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:05:21Z","timestamp":1789070721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0039625726000809"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.005","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroids for the treatment of diabetic macular edema with massive hard exudates: An evidence-based update.","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}